Abstract:
The antibacterial agents of this invention present the following structural formula: ##SPC1## 
     In which 
     A is a member selected from the group consisting of ##EQU1## M is a member selected from the group consisting of --H, an alkali metal and --NH 4  ; and 
     Y is a member selected from the group consisting of ##EQU2## wherein R is --H, alkanoyloxy of 2 to 6 carbon atoms, ##SPC2## 
     Or, 
     When taken with the 3-carboxy group, ##SPC3##.

Description:
DESCRIPTION OF THE INVENTION 
     In accordance with this invention there is provided antibacterial agents of the formula: ##SPC4## 
     In which 
     A is a member selected from the group 
     Consisting of ##EQU3## M is a member selected from the group consisting of --H, an alkali metal and --NH 4  ; and 
     Y is a member selected from the group consisting of ##EQU4## R is -H, alkanoyloxy of 2 to 6 carbon atoms, ##SPC5## 
     Or, when taken with the 3-carboxy group, ##SPC6## 
     The compounds of this invention are prepared by coupling techniques well known to the chemical arts. Thus, dehydrative coupling or mixed anhydride coupling as applied in the area of peptide synthesis are especially useful methods for the coupling reactions involved in the formation of the amides of 7-aminocephalosporanic acid derivatives and 6-amino penicillanic acid derivatives. In addition, the carboxylic acid intial reactants may, if desired, be converted to the corresponding acid halide by conventional means for use as the desired acylating agent. 
     The preferred cephalosporin derivatives from the standpoint of availability of reactants, ease of reaction and production economics are 7-amino-cephalosporanic acid and its desacetoxy analogue. However, those cephalosporin derivatives containing the ##SPC7## 
     Groups are recognized antibacterially equivalent derivations of the cephalosporanic acid moiety, as are the alkali metal and ammonium salts of the 3-carboxylic acid group. 
     3(4-Biphenylylcarbonyl)propionic acid is a known compound. The 3-(4-biphenylylcarbonyl)propionic acid O-methyloxime is prepared by refluxing equimolar amounts of 3-(4-biphenylylcarbonyl)propionic acid dissolved in dimethoxyethane and methoxyamine hydrochloride dissolved in an aqueous solution containing a molar equivalent of sodium acetate. 
     The compounds of this invention have been found to be active antibacterials effective against gram-positive and gram-negative test organisms as well as penicillin resistant staphlococcus, by using the well known and scientifically accepted agar serial dilution testing technique. Thus, the compounds of this invention are useful in the fields of comparative pharmacology and in microbiology and may be used for the treatment of bacterial infections amenable to treatment with penicillin and cephalosporin antibiotics. 
     The following examples illustrate the preparation of representative pencillin and cephalosporin derivatives. The activity of each product of the examples is presented for those specific bacterial strains against which the compound exemplified was active at or below 250 micrograms per milliliter. The representative nature of the bacterial strains employed to demonstrate antibacterial activity are indicative of the broader applicability of the compounds of this invention in the control of bacterial infestations other than those specifically referred to in each of the following examples. The bacterium are named followed by the specific strain and the concentration in micrograms per milliliter at which 100 percent inhibition occurred. The abbreviations for each bacterium are: 
     
         BA   SU             Bacillus subtilisHE   SP             Herellea speciesKL   PN             Klebsiella pneumoniaeNE   CA             Neisseria catarrhalisPR   VU             Proteus vulgarisST   AU             Staphylococcus aureus 
    
    
    
     EXAMPLE I 
     7-[3-(4-Biphenylylcarbonyl)propionamido]cephalosporanic acid. 
     To a tetrahydrofuran solution of 1.27 grams (5 millimole) of 3-(4-biphenylylcarbonyl)propionic acid in a salt-ice bath is added successively 0.50 gram of triethylamine and 0.70 gram (5 millimoles) of isobutyl chloroformate. After the solution is stirred for 15 minutes a cold solution of 1.36 grams (5 millimoles) of 7-aminocephalosporanic acid in a mixture of 20 milliliters tetrahydrofuran 0.5 g. of triethylamme and 10 milliliters H 2  O is added. The mixture is stirred in the ice-bath for 1 hour and at room temperature for 1 hour. After some solid is filtered off, the filtrate is evaporated under reduced pressure at approximately 30°C. The residue is dissolved in 50 milliliters H 2  O and some gelatinous solid is filtered off. The aqueous solution is acidified with a 6 N HCl solution to pH 2 in an ice-bath. The solid is collected and washed well with H 2  O and then dissolved in ethyl acetate. The ethyl acetate solution is dried over anhydrous MgSo 4 . The residue that results after removal of the solvent is treated with diethyl ether and collected. The product (1.3 grams) is obtained as a polymorphous solid. 
     Elemental Analysis for C 26  H 24  N 2  O 7  S.1/2H 2  O: Calc&#39;d: C, 60.33; H, 4.87; N, 5.41. Found: C, 60.77; H, 4.99; N, 5.25. 
     
         ______________________________________BA   SU          6633          .488KL   PN          10031         31.3NE   CA          8193          31.3ST   AU          6538P         .244ST   AU          SMITH         .244ST   AU          CHP           1.95ST   AU          53-180        .976______________________________________ 
    
     EXAMPLE II 
     6-[3-(4-Biphenylylcarbonyl)propionamido]penicillanic acid. 
     The title compound is prepared by the procedure described in Example I, except that 6-aminopenicillanic acid is substituted for the 7-aminocephalosporanic acid. 
     Elemental Analysis for C 24  H 24  N 2  O 5  S.1/2H 2  O: Calc&#39;d: C, 62.46; H, 5.46; N, 6.07. Found: C, 62-49; H, 5.74; N, 5.81. 
     
         ______________________________________BA   SU          6633          3.90HE   SP          9955          31.3KL   PN          10031         125NE   CA          8193          3.90ST   AU          6538P         .122ST   AU          SMITH         .122ST   AU          CHP           7.81______________________________________ 
    
     EXAMPLE III 
     7-[3-(4-Biphenylylcarbonyl)propionamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. 
     The title compound is prepared by the procedure described in Example I except that 7-aminodesacetoxycephalosporanic acid is substituted for 7-aminocephalosporanic acid. 
     Elemental Analysis for C 24  H 22  N 2  O 5  S: Calc&#39;d: C, 63.71; H, 5.35; N, 6.19. Found C, 63.62; H, 5.04; N, 5.86. 
     
         ______________________________________BA   SU          6633          3.90ST   AU          6538P         1.95ST   AU          SMITH         1.95ST   AU          CHP           3.90ST   AU          53-180        3.90______________________________________ 
    
     EXAMPLE IV 
     6-[3-(4-Biphenylylcarbonyl)propionamido]penicillanic acid O-methyloxime. 
     3-(4-Biphenylylcarbonyl)propionic acid (22.2 grams, 0.05 mole) is dissolved in 300 milliliters of dimethoxyethane. To the above solution an aqueous solution of methoxyamine hydrochloride (4.18 grams, 0.05 mole) and sodium acetate (4.10 grams, 0.05 mole) in 100 milliliter H 2  O is added. The mixture is heated to reflux for 18 hours. After a small amount of insoluble material is filtered off the solvent is removed under reduced pressure. The residual solid is dissolved in chloroform. The chloroform solution is washed with water and then dried over anhydrous magnesium sulfate. After the solvent is removed the crude material weighs 12.4 grams. The crude material is recrystallized from benzene. The recrystallized 3-(4-biphenylylcarbonyl)propionic acid o-methyl-oxamic melts at 152°-4°C. 
     Elemental Analysis for C 17  H 17  NO 3  : Calc&#39;d: C, 72.06; H, 6.05; N, 4.94. Found: C, 72.72; H, 6.12; N, 4.03. 
     The title compound is prepared by the procedure described in Example 1, except that 3-(4-biphenylylcarbonyl)propionic acid O-methyloxime and 6-aminopenicillanic acid are used. 
     Elemental Analysis for C 25  H 27  N 3  O 5  S: Calc&#39;d: C, 62.36; H, 5.65; N, 8.73. Found: C, 61.95; H, 5.88; N, 8.20. 
     
         ______________________________________BA   SU          6633          15.6HE   SP          9955          125NE   CA          8193          7.81ST   AU          6538P         .244ST   AU          SMITH         .244ST   AU          CHP           62.5______________________________________ 
    
     EXAMPLE V 
     7-[3-(4-Biphenylylcarbonyl)propionamido]cephalosporanic acid O-methyloxime. 
     The title compound is prepared by the procedure described in Example I except that 3-(4-biphenylylcarbonyl)propionic acid O-methyloxime, as produced in the preceding Example, is used. 
     Elemental Analysis for C 27  H 27  N 3  O 7  S: Calc&#39;d: C, 60.32; H, 5.06; N, 7.82. Found: C, 60.58; H, 5.26; N, 7.40. 
     
         ______________________________________BA        SU     6633          .488KL        PN     10031         250NE        CA     8193          31.3ST        AU     6538P         .488ST        AU     SMITH         .488ST        AU     CHP           .976ST        AU     53-180        1.95______________________________________